A high risk value for IBC patients was associated with a high mortality rate, which was consistent with the results of Kaplan–Meier analysis, also, the expression of WAKMAR2 was associated with risk status in different group (Fig. 3f). This evidence concerns the gene WAKMAR2 and inflammatory breast carcinoma.